3rd Measuring Patient Engagement Summit The Colonnade, Boston

Patient engagement is no longer optional – it’s a strategic imperative.

Regulators expect defensible evidence, executives demand clear ROI, and tighter funding and portfolio scrutiny mean every engagement activity must demonstrate real value. Yet across the industry, organizations still struggle to prove the impact of their efforts.

The 3rd Measuring Patient Engagement Summit is the only forum entirely focused on turning patient engagement strategies into measurable, credible impact. Over three days, 70+ senior leaders from pharma, biotech, and patient advocacy will convene to explore frameworks, tools, and practical approaches that show how patient input drives outcomes across development, access, and commercialization.

Through immersive workshops, hands-on case studies, and collaborative discussions, you will:
– Move beyond anecdotal reporting to defensible, outcome-based evidence
– Benchmark strategies, co-create frameworks, and track patient impact across multi-year programs
– Translate engagement into measurable influence for regulators, executives, and patient communities
– Leave equipped with peer-tested approaches, practical frameworks, and actionable insights to elevate your patient engagement from activity to strategic, measurable value

Measuring activity is no longer enough – demonstrating impact is what moves the industry forward.